The data from 2023 indicates a rapidly growing interest to conduct research at MAX IV. The latest Open Call, which closed in March 2024, received an all-time high of 459 proposals from national and international researchers who applied to use MAX IV this autumn. The total number of proposals submitted in the 2023 Open Calls
The news announced by the Swedish Ministry of Education and Research refers to a change in the ordinance 2009:975, which includes instructions for the Swedish Research Council as an authority. The change aims to reduce financial unpredictability and uncertainty due to short-term funding, enabling more long-term planning and stability. It has the potential to positively affect
COHERENCE is a top international meeting on developing and using coherent scattering methods with X-rays, EUV, electrons, lasers, and more. It attracts researchers from many fields (physics, chemistry, biology, optics, and more) interested in developing coherence-based methods and their applications. This 11th edition of the conference will be an in-person event hosted at the Clarion
The Government asks a number of referral bodies, including universities, government agencies, and other organisations, to give input and suggestions to their proposed research and innovation politics. Here is a list of submitted replies to the Government from different organisations. The input to the Research Bill submitted by Lund University includes input from MAX IV.
On November 1, 2022, we announced the opening of ForMAX, a beamline specially designed primarily for research on new, sustainable wood-based materials from the forest. The beamline also provides new capabilities for research on materials within food, life science and many other areas. Throughout this first year, we have reached several milestones with ForMAX together
“This is short-term – something we have to do now – but it is part of a much bigger journey and a big story about Sweden and innovation,” said Mats Persson, Swedish Minister for Education, during his visit at MAX IV. “Many interested groups are knocking on the doors of MAX IV and want to
MAX IV and the Industry 2022 summarises how the industry benefitted from MAX IV during the last year. It features industry user statistics, user cases, the results of various outreach and community-building efforts, and collaborations for national and international research. 50% more paid industry experiments The report concludes that the number of paid industry experiments
A recent finding has indicated that the amino acid-derived metabolite imidazole propionate (ImP) in patients with type 2 diabetes could contribute to impaired glucose tolerance and reduced insulin signalling. The ImP is produced by the bacterial enzyme urocanate reductase (UrdA). Based on this, blocking ImP production could potentially reduce diabetic symptoms in patients. However, challenges
Cancer accounts for nearly one out of six deaths yearly. It begins when one or more genes in a cell mutate, creating an abnormal protein or preventing a protein’s formation. Therefore, you need to start at the protein level to fight cancer. Sprint Bioscience is working to develop new drug candidates by identifying small molecules
Today, global food packaging and processing company Tetra Pak announces the commencement of new research using advanced X-ray scattering imaging techniques at ForMAX, the newest beamline at MAX IV laboratory. The study aims to uncover fresh insights into the nanostructure of fibre materials, with the first application to optimise the composition of materials used for